·
4 Min Read

Feb. 22, 2018: State Advocacy Update

Aetna's prior authorization program under scrutiny and MAT helps reduce post-incarceration fatal opioid-related overdoses in the latest AMA state advocacy news.

Advocacy Update
·
4 Min Read

Feb. 9, 2018: State Advocacy Update

"Share Your Story" initiative on ending opioid epidemic and more in AMA's latest state advocacy news.

Advocacy Update
·
2 Min Read

AMA applauds FDA, FTC crackdown on sham opioid treatments

The AMA commended the FDA and FTC for issuing warning letters to the marketers and distributors of 12 opioid cessation products.

Press Releases
·
3 Min Read

Dec. 14, 2017: State Advocacy Update

AMA State Legislative Strategy Conference and research on patient variability, surgical care and opioid prescribing in AMA's latest efforts for state and local advocacy efforts.

Advocacy Update
#Best of 2017 Opioid Treatment
·
4 Min Read

Physicians took multifaceted approach to opioid epidemic in 2017

Doctors led fight against opioid epidemic by battling stigma and advocating for more resources, more treatment options and better access to pain care.

Behavioral Health
·
2 Min Read

AMA applauds FDA Commissioner Gottlieb on opioid treatment approach

AMA enthusiastically supports FDA Commissioner Scott Gottlieb’s efforts to advance policies and actions to treat those suffering from an opioid use disorder.

Press Releases
·
3 Min Read

For patients struggling with opioids, ED visit can mark new start

Emergency departments emerge as places where opioid-use disorder treatment can be initiated and longer-term care coordinated.

Behavioral Health
Two physicians fill out paperwork at a table.
·
5 Min Read

Amid an epidemic, these physicians are taking action

Doctors encourage non-opioid approaches to pain and safe disposal of unwanted meds, and change the approach to post-surgical prescribing.

Behavioral Health
Crowd at large AMA meeting listening to a speaker
·
5 Min Read

AMA: Eliminate burdens for controlled substances’ e-prescribing

Delegates also push for effective opioid-use disorder in jails and prisons and emergency naloxone in public settings.

Interim Meeting